You are here

Acpharis CSO Speaks at Drug Discovery Chemistry Conference

Sandor Vajda, Acpharis CSO, spoke today at CHI's Drug Discovery Chemistry Conference in San Diego on the druggability of protein-protein interaction targets. By applying computational solvent mapping to these targets, one is able to find energetically favorable sites for the binding of fragment-sized molecules. The diversity of fragments that bind into these sites is a predictor of druggability, providing early information on the ability to drug members of this frequently intractable class of targets.